| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 03/06/2013 | CN101919810B Dexpanthenol infusion preparation and preparation method thereof |
| 03/06/2013 | CN101851233B Palonosetron hydrochloride, and precursor compound thereof |
| 03/06/2013 | CN101785581B Smoking-cessation and health-care cigarette holders and using method thereof |
| 03/06/2013 | CN101757039B Bionic enzymolysis products of geckos and application thereof |
| 03/06/2013 | CN101754751B Mixed metal compounds used as antacids |
| 03/06/2013 | CN101679273B 1-substituted tetrahydroisoquinoline compound |
| 03/05/2013 | US8389546 Compounds for modulating TRPV3 function |
| 03/05/2013 | US8389542 Dosage unit comprising a prostaglandin analog for treating constipation |
| 03/05/2013 | US8388977 Diagnosis of macrophage mediated disease |
| 03/05/2013 | US8388935 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 03/05/2013 | US8388934 Diagnostic agent |
| 03/05/2013 | CA2562144C Process for manufacturing spherical activated carbon |
| 02/28/2013 | WO2013028953A1 Combination treatments for hepatitis c |
| 02/28/2013 | WO2013028082A1 Antimicrobial composition |
| 02/28/2013 | WO2013027087A1 A non-reuterin-producing lactobacillus reuteri strain for treating helicobacter pylori infection |
| 02/28/2013 | WO2013026852A2 Derivatives of mecamylamine |
| 02/28/2013 | WO2013026558A2 Combined therapeutic agent |
| 02/28/2013 | WO2013026556A1 Monoterpene-containing agent for combination therapy |
| 02/28/2013 | WO2012167109A9 Rpgrip1 gene therapy for leber congenital amaurosis |
| 02/28/2013 | WO2012151248A3 FORMULATION FOR ANTI-α4β7 ANTIBODY |
| 02/28/2013 | US20130053449 Method for inhibiting histone gene transcription and expression |
| 02/28/2013 | US20130053446 Pharmaceutical preparations having individualized dosage and structure |
| 02/28/2013 | US20130053429 Treatment of Fibrosis Using Microrna 19b |
| 02/28/2013 | US20130053397 Indoles |
| 02/28/2013 | US20130053395 Pyrazolopyridine kinase inhibitors |
| 02/28/2013 | US20130053394 Pyrazolopyrimidine kinase inhibitors |
| 02/28/2013 | US20130053393 Methods and compositions for treating peripheral vascular disease |
| 02/28/2013 | US20130053388 Pyrazolopyrazine kinase inhibitors |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053380 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease |
| 02/28/2013 | US20130053375 Amino-quinolines as kinase inhibitors |
| 02/28/2013 | US20130053372 5-ht receptor modulators |
| 02/28/2013 | US20130053371 Inhibitors of pi3 kinase |
| 02/28/2013 | US20130053360 Controlled release and taste masking oral pharmaceutical composition |
| 02/28/2013 | US20130053359 NEW CYCLOHEXYLAMINE DERIVATIVES HAVING beta2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES |
| 02/28/2013 | US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3 |
| 02/28/2013 | US20130053354 Bone-transplant or bone-filling composition comprising a dihydroxybenzoic acid derivative |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053345 Bicyclic heteroarly analogues as gpr119 modulators |
| 02/28/2013 | US20130053340 Intestinal barrier integrity |
| 02/28/2013 | US20130053336 Treatment of chlamydiaceae infections by means of beta-lactams |
| 02/28/2013 | US20130053316 Methods for Treating Disorders of the Gastrointestinal Tract Using a GLP-1 Agonist |
| 02/28/2013 | US20130053315 Novel glp-1 derivatives |
| 02/28/2013 | US20130053313 New formulation for increasing bioavailability of neurturin |
| 02/28/2013 | US20130053308 4-AMINOPYRIMIDINE DERIVATIVES AND THEIR AS AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 02/28/2013 | US20130053304 Glucagon-like peptide-1 analogues and uses thereof |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052273 Pharmaceutical composition comprising periplaneta americana or its ethanol extract and a method of using the same for treating inflammations |
| 02/28/2013 | US20130052269 Formulations for oral delivery of adsorbents in the gut |
| 02/28/2013 | US20130052267 Methods of Inducing Tissue Regeneration |
| 02/28/2013 | US20130052213 Novel immunomodulatory peptide |
| 02/28/2013 | US20130052203 In vivo screening models for treatment of qc-related disorders |
| 02/28/2013 | US20130052197 Novel anti-cd98 antibody and use thereof |
| 02/28/2013 | US20130052195 Compositions Comprising TNF-alpha and IL-6 Antagonists and Methods of Use Thereof |
| 02/28/2013 | US20130052191 Anti-alpha2 integrin antibodies and their uses |
| 02/28/2013 | US20130052190 CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions |
| 02/28/2013 | US20130052185 Yeast hydrolysate having obesity treatment effects and antioxidant activity |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | US20130052174 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof |
| 02/28/2013 | US20130052170 Grafting material for genetic and cell therapy |
| 02/28/2013 | US20130052162 Boosting immune defense by upregulating ccaat/enhancer binding protein epsilon |
| 02/28/2013 | US20130052159 Methods for treatment of microbial disorders |
| 02/28/2013 | US20130052142 Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
| 02/28/2013 | CA2845321A1 Combination treatments for hepatitis c |
| 02/27/2013 | EP2561874A2 Pharmaceutical compositions for treating cancer |
| 02/27/2013 | EP2560732A2 A solid pharmaceutical composition for neutralizing stomach acid |
| 02/27/2013 | EP2560685A2 Methods and materials for reducing liver fibrosis |
| 02/27/2013 | EP2560660A1 Chemosensory receptor ligand-based therapies |
| 02/27/2013 | EP2560654A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives |
| 02/27/2013 | EP2560643A1 Compounds, compositions and methods comprising 1,3,4-oxadiazole derivatives |
| 02/27/2013 | EP2143444A9 Compositions for inhibition of angiogenesis |
| 02/27/2013 | CN202751611U Diffused particle for treating esophagus cancer |
| 02/27/2013 | CN202751609U Powder bag for double-viable-bacterium powders containing bifidobacteria and lactobacilli |
| 02/27/2013 | CN1886385B Crystals of phenylalanine derivatives and production methods thereof |
| 02/27/2013 | CN102947287A Cysteamine derivatives and their use in the treatment of nash |
| 02/27/2013 | CN102946898A Agent for reducing acetaldehyde in oral cavity |
| 02/27/2013 | CN102946885A Chemosensory receptor ligand-based therapies |
| 02/27/2013 | CN102946874A Compositions for dental treatment comprising lipoteichoic acids or parts thereof like mono- or polyglycerphosphates |
| 02/27/2013 | CN102946742A Use of human milk oligosaccharides in infant nutrition |
| 02/27/2013 | CN102943022A Yang-tonifying wine |
| 02/27/2013 | CN102942626A Glucagon-like peptide-2 analogue, its preparation method and application |
| 02/27/2013 | CN102942572A Crystal forms of (r)-n-methylnaltrexone bromide and uses thereof |
| 02/27/2013 | CN102942567A Disodium salt crystal of pyrroloquinoline quinone |
| 02/27/2013 | CN102942563A Polymorphic and other crystalline forms of cis-ftc |
| 02/27/2013 | CN102942557A Novel medicinal salt of dexlansoprazole |
| 02/27/2013 | CN102942551A Flavanol containing 3-nitro propionyl, medical composition contain same and application thereof in pharmacy |
| 02/27/2013 | CN102942522A Heterocyclic inhibitors of mek and methods of use thereof |
| 02/27/2013 | CN102940888A Targeted drug delivery method of pectin colon containing lecithin |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940876A Application of polypeptide GH27 in preparation of medicament for preventing and treating goat diarrhea |
| 02/27/2013 | CN102940871A Chinese medicament for treating chronic hepatitis |
| 02/27/2013 | CN102940869A Chinese medicinal composition for treating porcine diarrhea |
| 02/27/2013 | CN102940868A Chinese medicament for treating stomachache caused by deficiency and internal cold |
| 02/27/2013 | CN102940866A Traditional Chinese medicine composition for treating idiopathic chronic pancreatitis and preparation method thereof |
| 02/27/2013 | CN102940862A Traditional Chinese medicine for treating recurrent vomiting caused by chronic gastritis |
| 02/27/2013 | CN102940860A Traditional Chinese medicine composition for treating recurrent oral ulcer |
| 02/27/2013 | CN102940858A Edible traditional Chinese medicine composition and preparation method thereof |
| 02/27/2013 | CN102940855A Pharmaceutical composition for treating gastropathy and preparation method of pharmaceutically composition |
| 02/27/2013 | CN102940846A Traditional Chinese medicine composition for treating atrophic gastritis as welln as preparation method and application of composition |
| 02/27/2013 | CN102940845A Traditional Chinese medicine composition for treating gastritis as well as preparation method and application of composition |